Fosun International (HKEX stock code: 00656, hereinafter referred to as "Fosun International", "Fosun", or the "Company") has successfully completed the refinancing of a USD 870 million equivalent ...

Fosun International (OTCPK:FOSUF) refinanced a $870M syndicated loan due on March 28, 2025. Of this amount, $675M equivalent was secured through a newly arranged syndicated loan. Consistent with the ...

Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...

SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH ...

Why are Fosun holding on to the club and risking relegation every season? Would they consider appointing an experienced ...

Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group ...

Being in a position of relative safety means the club can now plan early for next season, but will they make the most of it?

Brian asked: Why are Fosun holding on to the club and risking relegation every season? Would they consider appointing an experienced director of football to allow Jeff Shi to run the business side?

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...

SHANGHAI -- Chinese drugmaker Fosun Pharmaceutical Group has agreed to sell its stake in a hospital group to U.S. private equity firm Warburg Pincus for $124.08 million.